These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 7520393

  • 1. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F, Snoeck HW, Nijs G, Lenjou M, Peetermans ME, Rodrigus I, Berneman ZN, Van Bockstaele DR.
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Aug; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 7. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF.
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 9. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE, Ruscetti FW, Ortiz M, Gooya JM, Keller JR.
    Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
    [Abstract] [Full Text] [Related]

  • 10. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 11. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
    Kriegler AB, Verschoor SM, Bernardo D, Bertoncello I.
    Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Hoffman R, Law P, Srour EF.
    Blood Cells; 1994 May; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of interleukin-3, interleukin-6, and stem cell factor on retroviral transduction of rhesus monkey CD34+ hematopoietic progenitor cells measured in vitro and in vivo.
    van Beusechem VW, Bart-Baumeister JA, Hoogerbrugge PM, Valerio D.
    Gene Ther; 1995 Jun; 2(4):245-55. PubMed ID: 7552984
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta inhibits the action of stem cell factor on mouse and human hematopoietic progenitors.
    McNiece IK, Bertoncello I, Keller JR, Ruscetti FW, Hartley CA, Zsebo KM.
    Int J Cell Cloning; 1992 Mar; 10(2):80-6. PubMed ID: 1372030
    [Abstract] [Full Text] [Related]

  • 18. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
    Tsujino Y, Wada H, Misawa M, Kai S, Hara H.
    Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
    [Abstract] [Full Text] [Related]

  • 19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D, Lemoine FM, Najman A, Guigon M.
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.